The development of advanced industry and economy in Japan has brought us the prosperity enjoyed by industrialized nations, and secured our position in the world as an economic giant. As a result, the material well-being of our citizens improved to a point comparable to those of the most developed countries on the globe.
In the 1980s, there was a tidal shift towards the pursuit of health and affluence. The role of medical care took on even greater importance in the face of this trend as well as the fact of an aging society.
The improved standards and safety of medical care today owe much to advances in medical technology which itself is the result of consolidation of modern sciences, whether it be the development of biocompatible materials in the field of artificial organs, extraordinary advances in basic quality of medical equipment and the computerization of various diagnostic and monitoring devices.
One task of the globalization era is to ensure that Japanese medical technology makes its contribution to the front lines of health care throughout the world and helps build a peaceful future for humankind through healthy lives.
Given these circumstances, the founding purpose of our foundation is to invigorate science and technology in Japan through research subsidization, promotion and education, and support for international exchange as they relate to science and technology in the field of life sciences.
To subsidize and promote research related to science and technology in the areas of life-science-related materials, bioengineering, biological defense mechanism, bioinstrumentation, and pathological biochemistry. The mission consists of research subsidization, promotion and education, recognition of exceptional achievements, and international exchange related to science and technology in the field of life sciences. Specifically, they are as follows:
- Special research subsidy (3-year subsidy at 10 million yen annually according to foundation-designated subjects)
- General research subsidy (1-year subsidy at 1 million yen annually according to foundation-designated subjects)
- International exchange subsidy (subsidies at 14 million yen annually for participation in, invitation of and travel to domestic academic conferences and other events, as well as co-sponsorship of overseas academic conferences and other events)
- Promotion and education through a life sciences web site for middle- and high-school students (operation and planning of an information web site for life sciences launched specifically for middle- and high-school students; content themes for the first year were the basics to practical application of regenerative medicine)
|Founded:||April 24, 1987|
(Value of owned TERUMO Corporation’s stocks as of March 31, 2015 plus fixed deposit)
|Endowing Organization:||TERUMO Corporation|
|Scale of Operation:||Approx. 177,000,000 yen/ year (2014 results)|
|The Organization:||1 president, 1 vice-president, 8 directors, 1 managing director, 2 auditors, 9 councilors, 7 academic committee members, 25 selection committee members, 1 secretary-general|
1500 Inokuchi, Nakai-machi, Ashigarakami-gun, Kanagawa Prefecture, 259-0151 Japan
E-mail: email@example.com. jp